Question · Q4 2025
JP Wollam asked about the reception to the consumables price increase implemented in Q3, whether pricing might be a future lever, and what differentiates utilization between the company's best and worst partners. He also inquired about ongoing OpEx management, specifically potential offsets to new investments through centralizing international costs.
Answer
CFO Mike Monahan confirmed a 5% price increase on consumables at the beginning of Q3, which was successful with little pushback, and the sales and marketing team continues to evaluate pricing. CEO Pedro Malha noted that providers who understand how to prescribe boosters use roughly three times more, highlighting the importance of marketing and education. Mike Monahan also discussed creating shared service centers to manage the global business effectively and gain cost efficiencies, expecting this process to be finalized by the end of the year. He stated that G&A is expected to be stable to slightly up due to R&D reinvestment, but there's long-term opportunity for efficiencies and operating leverage as the business returns to growth.
Ask follow-up questions
Fintool can predict
SKIN's earnings beat/miss a week before the call